Calcineurin Inhibitors and Male Fertility in Renal Transplant Recipients: A Comprehensive Review of Molecular Pathomechanisms and Reproductive Toxicity of Cyclosporine A and Tacrolimus.
- 1Department of Histology and Developmental Biology, Faculty of Health Sciences, Pomeranian Medical University, Żołnierska 48, 71-210 Szczecin, Poland.
Abstract
This comprehensive review provides a detailed organ-resolved and translational synthesis of the effects of calcineurin inhibitors, such as cyclosporine A (CsA) and tacrolimus (FK506), on male reproductive function following kidney transplantation. This review summarises experimental and clinical evidence relating to the testes, epididymis, accessory glands, the hypothalamic-pituitary-gonadal axis and semen parameters. It also considers molecular mechanisms, clinical outcomes and transplant-related confounding factors. Experimental evidence indicates that calcineurin inhibitors can cause testicular injury in a dose- and duration-dependent manner, resulting in seminiferous epithelium disorganisation, impaired Sertoli-germ cell interactions, Leydig cell atrophy, reduced testosterone synthesis, and reduced sperm count and motility. In animal models, CsA appears to induce more pronounced histological and steroidogenic disruption. In contrast, murine studies suggest that FK506 primarily exerts molecular alterations on post-testicular sperm maturation. Proposed preclinical mechanisms include oxidative stress, mitochondrial dysfunction, apoptosis and microvascular remodelling. However, their direct role in human recipients remains to be fully verified. Clinical findings demonstrated that successful transplantation often improves pre-existing uremic hypogonadism, and semen quality usually recovers within one to two years, particularly with stable graft function and lower calcineurin inhibitor exposure. However, persistent abnormalities can occur, and outcomes are confounded by, among others, renal function or combination therapy. It is important to distinguish direct calcineurin inhibitor-induced reproductive toxicity from the confounding effects of chronic kidney disease, prior dialysis exposure, and glucocorticoid use, as these transplant-related factors significantly modulate gonadal function independently of calcineurin inhibition.
Related
- Impaired Erythropoietin Production in Liver Transplant Recipients: the Role of Calcineurin Inhibitors
- Calcineurin inhibitors treatment in kidney transplant recipients is frequently associated with hyperkalemia, acidosis and hypertension but not with increased expression or phosphorylation of the sodium chloride cotransporter
- Expectations for Angiopoietin-like 3 Inhibitors Taking Broad Lipid-modifying Effects on the Comprehensive Control of Atherosclerotic Cardiovascular Disease Risk in Patients with Homozygous Familial Hypercholesterolemia
- Elevated cardiovascular risk associated with hormone replacement therapy: A comprehensive analysis of reproductive factors and atherosclerotic cardiovascular disease outcomes in the UK Biobank cohort
- Potassium-competitive acid blockers and proton-pump inhibitors for the healing and maintenance of erosive esophagitis: a comprehensive and updated systematic review with network meta-analysis
BibTeX
@article{grabowska2026calcineurin,
title = {{Calcineurin Inhibitors and Male Fertility in Renal Transplant Recipients: A Comprehensive Review of Molecular Pathomechanisms and Reproductive Toxicity of Cyclosporine A and Tacrolimus.}},
author = {Marta Grabowska and Małgorzata Piasecka},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
doi = {10.3390/ijms27198501},
url = {https://europepmc.org/article/MED/42883749},
note = {CC BY},
}
RIS
TY - JOUR
TI - Calcineurin Inhibitors and Male Fertility in Renal Transplant Recipients: A Comprehensive Review of Molecular Pathomechanisms and Reproductive Toxicity of Cyclosporine A and Tacrolimus.
AU - Marta Grabowska
AU - Małgorzata Piasecka
PY - 2026
DA - 2026/09/23
JO - International journal of molecular sciences
DO - 10.3390/ijms27198501
UR - https://europepmc.org/article/MED/42883749
AB - This comprehensive review provides a detailed organ-resolved and translational synthesis of the effects of calcineurin inhibitors, such as cyclosporine A (CsA) and tacrolimus (FK506), on male reproductive function following kidney transplantation. This review summarises experimental and clinical evidence relating to the testes, epididymis, accessory glands, the hypothalamic-pituitary-gonadal axis and semen parameters. It also considers molecular mechanisms, clinical outcomes and transplant-related confounding factors. Experimental evidence indicates that calcineurin inhibitors can cause testicular injury in a dose- and duration-dependent manner, resulting in seminiferous epithelium disorganisation, impaired Sertoli-germ cell interactions, Leydig cell atrophy, reduced testosterone synthesis, and reduced sperm count and motility. In animal models, CsA appears to induce more pronounced histological and steroidogenic disruption. In contrast, murine studies suggest that FK506 primarily exerts molecular alterations on post-testicular sperm maturation. Proposed preclinical mechanisms include oxidative stress, mitochondrial dysfunction, apoptosis and microvascular remodelling. However, their direct role in human recipients remains to be fully verified. Clinical findings demonstrated that successful transplantation often improves pre-existing uremic hypogonadism, and semen quality usually recovers within one to two years, particularly with stable graft function and lower calcineurin inhibitor exposure. However, persistent abnormalities can occur, and outcomes are confounded by, among others, renal function or combination therapy. It is important to distinguish direct calcineurin inhibitor-induced reproductive toxicity from the confounding effects of chronic kidney disease, prior dialysis exposure, and glucocorticoid use, as these transplant-related factors significantly modulate gonadal function independently of calcineurin inhibition.
SN - 1422-0067
ER -